nodes	percent_of_prediction	percent_of_DWPC	metapath
Glipizide—PPARG—colon cancer	0.803	1	CbGaD
Glipizide—CYP2C9—Capecitabine—colon cancer	0.0343	0.441	CbGbCtD
Glipizide—CYP2C9—Fluorouracil—colon cancer	0.0204	0.262	CbGbCtD
Glipizide—CYP3A4—Irinotecan—colon cancer	0.0123	0.158	CbGbCtD
Glipizide—CYP3A4—Vincristine—colon cancer	0.0108	0.139	CbGbCtD
Glipizide—PPARG—Topotecan—Irinotecan—colon cancer	0.00485	1	CbGdCrCtD
Glipizide—Gliclazide—VEGFA—colon cancer	0.00255	0.749	CrCbGaD
Glipizide—PPARG—endothelium—colon cancer	0.00231	0.122	CbGeAlD
Glipizide—PPARG—blood vessel—colon cancer	0.00213	0.112	CbGeAlD
Glipizide—ABCC8—smooth muscle tissue—colon cancer	0.00131	0.069	CbGeAlD
Glipizide—PPARG—embryo—colon cancer	0.00127	0.067	CbGeAlD
Glipizide—ABCC8—renal system—colon cancer	0.00126	0.0665	CbGeAlD
Glipizide—KCNJ11—lymphoid tissue—colon cancer	0.00114	0.0599	CbGeAlD
Glipizide—PPARG—epithelium—colon cancer	0.00104	0.0547	CbGeAlD
Glipizide—PPARG—smooth muscle tissue—colon cancer	0.001	0.0527	CbGeAlD
Glipizide—PPARG—renal system—colon cancer	0.000963	0.0507	CbGeAlD
Glipizide—Polyuria—Vincristine—colon cancer	0.000859	0.00929	CcSEcCtD
Glipizide—Eruption—Methotrexate—colon cancer	0.000819	0.00886	CcSEcCtD
Glipizide—PPARG—lymphoid tissue—colon cancer	0.0008	0.0421	CbGeAlD
Glipizide—PPARG—digestive system—colon cancer	0.00079	0.0416	CbGeAlD
Glipizide—Visual disturbance—Irinotecan—colon cancer	0.000775	0.00838	CcSEcCtD
Glipizide—Hyponatraemia—Vincristine—colon cancer	0.000757	0.00819	CcSEcCtD
Glipizide—Liver disorder—Methotrexate—colon cancer	0.000739	0.008	CcSEcCtD
Glipizide—Hyponatraemia—Irinotecan—colon cancer	0.000737	0.00797	CcSEcCtD
Glipizide—Gastrointestinal haemorrhage—Irinotecan—colon cancer	0.000734	0.00794	CcSEcCtD
Glipizide—PPARG—bone marrow—colon cancer	0.000728	0.0384	CbGeAlD
Glipizide—Gastrointestinal haemorrhage—Fluorouracil—colon cancer	0.000703	0.0076	CcSEcCtD
Glipizide—PPARG—vagina—colon cancer	0.000697	0.0367	CbGeAlD
Glipizide—Gait disturbance—Capecitabine—colon cancer	0.000694	0.0075	CcSEcCtD
Glipizide—KCNJ11—lymph node—colon cancer	0.000642	0.0338	CbGeAlD
Glipizide—Pancytopenia—Vincristine—colon cancer	0.000619	0.00669	CcSEcCtD
Glipizide—Urine output increased—Capecitabine—colon cancer	0.000612	0.00662	CcSEcCtD
Glipizide—Dysuria—Vincristine—colon cancer	0.000609	0.00659	CcSEcCtD
Glipizide—Photosensitivity reaction—Vincristine—colon cancer	0.000595	0.00643	CcSEcCtD
Glipizide—Abnormal vision—Capecitabine—colon cancer	0.00059	0.00638	CcSEcCtD
Glipizide—PPARG—liver—colon cancer	0.000588	0.031	CbGeAlD
Glipizide—Pancytopenia—Fluorouracil—colon cancer	0.000577	0.00624	CcSEcCtD
Glipizide—Hepatic function abnormal—Capecitabine—colon cancer	0.000562	0.00608	CcSEcCtD
Glipizide—Polyuria—Capecitabine—colon cancer	0.00056	0.00605	CcSEcCtD
Glipizide—Sweating—Vincristine—colon cancer	0.000557	0.00602	CcSEcCtD
Glipizide—Photosensitivity reaction—Fluorouracil—colon cancer	0.000555	0.006	CcSEcCtD
Glipizide—Jaundice—Irinotecan—colon cancer	0.000552	0.00596	CcSEcCtD
Glipizide—Haemolytic anaemia—Capecitabine—colon cancer	0.000544	0.00589	CcSEcCtD
Glipizide—Sweating—Irinotecan—colon cancer	0.000542	0.00587	CcSEcCtD
Glipizide—Libido decreased—Capecitabine—colon cancer	0.00053	0.00573	CcSEcCtD
Glipizide—Conjunctivitis—Fluorouracil—colon cancer	0.000527	0.0057	CcSEcCtD
Glipizide—Hypoaesthesia—Vincristine—colon cancer	0.000519	0.00561	CcSEcCtD
Glipizide—Thirst—Capecitabine—colon cancer	0.000516	0.00558	CcSEcCtD
Glipizide—Rhinitis—Irinotecan—colon cancer	0.000509	0.00551	CcSEcCtD
Glipizide—Chlorpropamide—ABCB1—colon cancer	0.000508	0.15	CrCbGaD
Glipizide—Agranulocytosis—Fluorouracil—colon cancer	0.000506	0.00547	CcSEcCtD
Glipizide—Hyponatraemia—Capecitabine—colon cancer	0.000493	0.00534	CcSEcCtD
Glipizide—Diplopia—Capecitabine—colon cancer	0.000491	0.00531	CcSEcCtD
Glipizide—Gastrointestinal haemorrhage—Capecitabine—colon cancer	0.000491	0.00531	CcSEcCtD
Glipizide—Visual impairment—Irinotecan—colon cancer	0.000489	0.00529	CcSEcCtD
Glipizide—Rhinitis—Fluorouracil—colon cancer	0.000488	0.00527	CcSEcCtD
Glipizide—Disturbance in sexual arousal—Capecitabine—colon cancer	0.000487	0.00527	CcSEcCtD
Glipizide—Hypoaesthesia—Fluorouracil—colon cancer	0.000484	0.00523	CcSEcCtD
Glipizide—Migraine—Capecitabine—colon cancer	0.000484	0.00523	CcSEcCtD
Glipizide—Pharyngitis—Fluorouracil—colon cancer	0.000483	0.00522	CcSEcCtD
Glipizide—Aplastic anaemia—Methotrexate—colon cancer	0.000473	0.00512	CcSEcCtD
Glipizide—Flushing—Irinotecan—colon cancer	0.000471	0.0051	CcSEcCtD
Glipizide—CYP2C9—digestive system—colon cancer	0.000462	0.0244	CbGeAlD
Glipizide—Chills—Irinotecan—colon cancer	0.000456	0.00493	CcSEcCtD
Glipizide—Urine output increased—Methotrexate—colon cancer	0.000456	0.00493	CcSEcCtD
Glipizide—Arrhythmia—Irinotecan—colon cancer	0.000454	0.00491	CcSEcCtD
Glipizide—PPARG—lymph node—colon cancer	0.000451	0.0238	CbGeAlD
Glipizide—Abdominal pain upper—Capecitabine—colon cancer	0.000449	0.00485	CcSEcCtD
Glipizide—Flatulence—Irinotecan—colon cancer	0.000436	0.00471	CcSEcCtD
Glipizide—Arrhythmia—Fluorouracil—colon cancer	0.000435	0.0047	CcSEcCtD
Glipizide—CYP3A4—renal system—colon cancer	0.00043	0.0227	CbGeAlD
Glipizide—Muscle spasms—Irinotecan—colon cancer	0.000425	0.0046	CcSEcCtD
Glipizide—Erythema—Fluorouracil—colon cancer	0.000423	0.00458	CcSEcCtD
Glipizide—Polyuria—Methotrexate—colon cancer	0.000417	0.00451	CcSEcCtD
Glipizide—Ill-defined disorder—Irinotecan—colon cancer	0.00041	0.00444	CcSEcCtD
Glipizide—Vertigo—Vincristine—colon cancer	0.000408	0.00441	CcSEcCtD
Glipizide—Abdominal discomfort—Capecitabine—colon cancer	0.000407	0.0044	CcSEcCtD
Glipizide—Leukopenia—Vincristine—colon cancer	0.000406	0.0044	CcSEcCtD
Glipizide—Pancytopenia—Capecitabine—colon cancer	0.000403	0.00436	CcSEcCtD
Glipizide—Vision blurred—Fluorouracil—colon cancer	0.000399	0.00432	CcSEcCtD
Glipizide—Malaise—Irinotecan—colon cancer	0.000399	0.00431	CcSEcCtD
Glipizide—Vertigo—Irinotecan—colon cancer	0.000397	0.0043	CcSEcCtD
Glipizide—Dysuria—Capecitabine—colon cancer	0.000397	0.00429	CcSEcCtD
Glipizide—Syncope—Irinotecan—colon cancer	0.000397	0.00429	CcSEcCtD
Glipizide—Leukopenia—Irinotecan—colon cancer	0.000396	0.00428	CcSEcCtD
Glipizide—Hypertension—Vincristine—colon cancer	0.000392	0.00424	CcSEcCtD
Glipizide—Loss of consciousness—Irinotecan—colon cancer	0.000389	0.0042	CcSEcCtD
Glipizide—Photosensitivity reaction—Capecitabine—colon cancer	0.000388	0.00419	CcSEcCtD
Glipizide—Myalgia—Vincristine—colon cancer	0.000387	0.00418	CcSEcCtD
Glipizide—Visual disturbance—Methotrexate—colon cancer	0.000386	0.00417	CcSEcCtD
Glipizide—Hypertension—Irinotecan—colon cancer	0.000382	0.00413	CcSEcCtD
Glipizide—Leukopenia—Fluorouracil—colon cancer	0.000379	0.0041	CcSEcCtD
Glipizide—Discomfort—Irinotecan—colon cancer	0.000372	0.00402	CcSEcCtD
Glipizide—Oedema—Vincristine—colon cancer	0.000371	0.00401	CcSEcCtD
Glipizide—Jaundice—Capecitabine—colon cancer	0.000369	0.00399	CcSEcCtD
Glipizide—Conjunctivitis—Capecitabine—colon cancer	0.000368	0.00398	CcSEcCtD
Glipizide—Confusional state—Irinotecan—colon cancer	0.000364	0.00393	CcSEcCtD
Glipizide—Thrombocytopenia—Vincristine—colon cancer	0.000363	0.00392	CcSEcCtD
Glipizide—Oedema—Irinotecan—colon cancer	0.000361	0.0039	CcSEcCtD
Glipizide—Myalgia—Fluorouracil—colon cancer	0.000361	0.0039	CcSEcCtD
Glipizide—Hyperhidrosis—Vincristine—colon cancer	0.000358	0.00387	CcSEcCtD
Glipizide—Hepatobiliary disease—Capecitabine—colon cancer	0.000358	0.00387	CcSEcCtD
Glipizide—Discomfort—Fluorouracil—colon cancer	0.000356	0.00385	CcSEcCtD
Glipizide—Shock—Irinotecan—colon cancer	0.000355	0.00384	CcSEcCtD
Glipizide—Agranulocytosis—Capecitabine—colon cancer	0.000353	0.00382	CcSEcCtD
Glipizide—Thrombocytopenia—Irinotecan—colon cancer	0.000353	0.00382	CcSEcCtD
Glipizide—Anorexia—Vincristine—colon cancer	0.000353	0.00382	CcSEcCtD
Glipizide—CYP3A4—digestive system—colon cancer	0.000353	0.0186	CbGeAlD
Glipizide—Hyperhidrosis—Irinotecan—colon cancer	0.000349	0.00377	CcSEcCtD
Glipizide—Confusional state—Fluorouracil—colon cancer	0.000348	0.00377	CcSEcCtD
Glipizide—Oedema—Fluorouracil—colon cancer	0.000346	0.00374	CcSEcCtD
Glipizide—CYP2C9—liver—colon cancer	0.000345	0.0182	CbGeAlD
Glipizide—Anorexia—Irinotecan—colon cancer	0.000344	0.00372	CcSEcCtD
Glipizide—Glyburide—ABCB1—colon cancer	0.000343	0.101	CrCbGaD
Glipizide—Rhinitis—Capecitabine—colon cancer	0.000341	0.00369	CcSEcCtD
Glipizide—Hepatitis—Capecitabine—colon cancer	0.00034	0.00368	CcSEcCtD
Glipizide—Thrombocytopenia—Fluorouracil—colon cancer	0.000338	0.00366	CcSEcCtD
Glipizide—Hypoaesthesia—Capecitabine—colon cancer	0.000338	0.00366	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Vincristine—colon cancer	0.000338	0.00365	CcSEcCtD
Glipizide—Pharyngitis—Capecitabine—colon cancer	0.000337	0.00365	CcSEcCtD
Glipizide—Insomnia—Vincristine—colon cancer	0.000335	0.00362	CcSEcCtD
Glipizide—Paraesthesia—Vincristine—colon cancer	0.000333	0.0036	CcSEcCtD
Glipizide—Anorexia—Fluorouracil—colon cancer	0.000329	0.00356	CcSEcCtD
Glipizide—Visual impairment—Capecitabine—colon cancer	0.000328	0.00354	CcSEcCtD
Glipizide—Insomnia—Irinotecan—colon cancer	0.000326	0.00353	CcSEcCtD
Glipizide—Paraesthesia—Irinotecan—colon cancer	0.000324	0.0035	CcSEcCtD
Glipizide—Decreased appetite—Vincristine—colon cancer	0.000322	0.00348	CcSEcCtD
Glipizide—Dyspnoea—Irinotecan—colon cancer	0.000322	0.00348	CcSEcCtD
Glipizide—Somnolence—Irinotecan—colon cancer	0.000321	0.00347	CcSEcCtD
Glipizide—Gastrointestinal disorder—Vincristine—colon cancer	0.00032	0.00346	CcSEcCtD
Glipizide—Eye disorder—Capecitabine—colon cancer	0.000318	0.00344	CcSEcCtD
Glipizide—Dyspepsia—Irinotecan—colon cancer	0.000318	0.00344	CcSEcCtD
Glipizide—Pain—Vincristine—colon cancer	0.000317	0.00343	CcSEcCtD
Glipizide—Constipation—Vincristine—colon cancer	0.000317	0.00343	CcSEcCtD
Glipizide—Flushing—Capecitabine—colon cancer	0.000315	0.00341	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000315	0.00341	CcSEcCtD
Glipizide—Decreased appetite—Irinotecan—colon cancer	0.000314	0.00339	CcSEcCtD
Glipizide—Insomnia—Fluorouracil—colon cancer	0.000313	0.00338	CcSEcCtD
Glipizide—Gastrointestinal disorder—Irinotecan—colon cancer	0.000312	0.00337	CcSEcCtD
Glipizide—Paraesthesia—Fluorouracil—colon cancer	0.00031	0.00336	CcSEcCtD
Glipizide—Pain—Irinotecan—colon cancer	0.000309	0.00334	CcSEcCtD
Glipizide—Constipation—Irinotecan—colon cancer	0.000309	0.00334	CcSEcCtD
Glipizide—Dyspnoea—Fluorouracil—colon cancer	0.000308	0.00333	CcSEcCtD
Glipizide—Somnolence—Fluorouracil—colon cancer	0.000307	0.00332	CcSEcCtD
Glipizide—Chills—Capecitabine—colon cancer	0.000305	0.0033	CcSEcCtD
Glipizide—Dyspepsia—Fluorouracil—colon cancer	0.000304	0.00329	CcSEcCtD
Glipizide—Arrhythmia—Capecitabine—colon cancer	0.000304	0.00328	CcSEcCtD
Glipizide—Abdominal discomfort—Methotrexate—colon cancer	0.000303	0.00328	CcSEcCtD
Glipizide—Gastrointestinal pain—Vincristine—colon cancer	0.000303	0.00328	CcSEcCtD
Glipizide—Decreased appetite—Fluorouracil—colon cancer	0.0003	0.00325	CcSEcCtD
Glipizide—Pancytopenia—Methotrexate—colon cancer	0.0003	0.00325	CcSEcCtD
Glipizide—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000298	0.00323	CcSEcCtD
Glipizide—Feeling abnormal—Irinotecan—colon cancer	0.000297	0.00322	CcSEcCtD
Glipizide—Erythema—Capecitabine—colon cancer	0.000296	0.0032	CcSEcCtD
Glipizide—Dysuria—Methotrexate—colon cancer	0.000296	0.0032	CcSEcCtD
Glipizide—Pain—Fluorouracil—colon cancer	0.000296	0.0032	CcSEcCtD
Glipizide—Gastrointestinal pain—Irinotecan—colon cancer	0.000295	0.00319	CcSEcCtD
Glipizide—Abdominal pain—Vincristine—colon cancer	0.000293	0.00317	CcSEcCtD
Glipizide—Flatulence—Capecitabine—colon cancer	0.000292	0.00315	CcSEcCtD
Glipizide—Photosensitivity reaction—Methotrexate—colon cancer	0.000289	0.00312	CcSEcCtD
Glipizide—Abdominal pain—Irinotecan—colon cancer	0.000285	0.00309	CcSEcCtD
Glipizide—Feeling abnormal—Fluorouracil—colon cancer	0.000285	0.00308	CcSEcCtD
Glipizide—Muscle spasms—Capecitabine—colon cancer	0.000285	0.00308	CcSEcCtD
Glipizide—Drowsiness—Methotrexate—colon cancer	0.000282	0.00305	CcSEcCtD
Glipizide—Vision blurred—Capecitabine—colon cancer	0.000279	0.00302	CcSEcCtD
Glipizide—Tremor—Capecitabine—colon cancer	0.000277	0.003	CcSEcCtD
Glipizide—Ill-defined disorder—Capecitabine—colon cancer	0.000275	0.00297	CcSEcCtD
Glipizide—Urticaria—Fluorouracil—colon cancer	0.000275	0.00297	CcSEcCtD
Glipizide—Conjunctivitis—Methotrexate—colon cancer	0.000274	0.00296	CcSEcCtD
Glipizide—Hypersensitivity—Vincristine—colon cancer	0.000273	0.00295	CcSEcCtD
Glipizide—Sweating—Methotrexate—colon cancer	0.00027	0.00292	CcSEcCtD
Glipizide—Malaise—Capecitabine—colon cancer	0.000267	0.00289	CcSEcCtD
Glipizide—Hepatobiliary disease—Methotrexate—colon cancer	0.000267	0.00288	CcSEcCtD
Glipizide—Vertigo—Capecitabine—colon cancer	0.000266	0.00288	CcSEcCtD
Glipizide—Hypersensitivity—Irinotecan—colon cancer	0.000266	0.00288	CcSEcCtD
Glipizide—Asthenia—Vincristine—colon cancer	0.000266	0.00288	CcSEcCtD
Glipizide—Syncope—Capecitabine—colon cancer	0.000265	0.00287	CcSEcCtD
Glipizide—Leukopenia—Capecitabine—colon cancer	0.000265	0.00286	CcSEcCtD
Glipizide—Agranulocytosis—Methotrexate—colon cancer	0.000263	0.00284	CcSEcCtD
Glipizide—CYP3A4—liver—colon cancer	0.000263	0.0138	CbGeAlD
Glipizide—Loss of consciousness—Capecitabine—colon cancer	0.00026	0.00281	CcSEcCtD
Glipizide—Asthenia—Irinotecan—colon cancer	0.000259	0.0028	CcSEcCtD
Glipizide—Hypertension—Capecitabine—colon cancer	0.000255	0.00276	CcSEcCtD
Glipizide—Hypersensitivity—Fluorouracil—colon cancer	0.000255	0.00275	CcSEcCtD
Glipizide—Diarrhoea—Vincristine—colon cancer	0.000254	0.00274	CcSEcCtD
Glipizide—Hepatitis—Methotrexate—colon cancer	0.000253	0.00274	CcSEcCtD
Glipizide—Arthralgia—Capecitabine—colon cancer	0.000252	0.00272	CcSEcCtD
Glipizide—Myalgia—Capecitabine—colon cancer	0.000252	0.00272	CcSEcCtD
Glipizide—Pharyngitis—Methotrexate—colon cancer	0.000251	0.00272	CcSEcCtD
Glipizide—Anxiety—Capecitabine—colon cancer	0.000251	0.00272	CcSEcCtD
Glipizide—Discomfort—Capecitabine—colon cancer	0.000249	0.00269	CcSEcCtD
Glipizide—Diarrhoea—Irinotecan—colon cancer	0.000247	0.00267	CcSEcCtD
Glipizide—Dizziness—Vincristine—colon cancer	0.000245	0.00265	CcSEcCtD
Glipizide—Pruritus—Fluorouracil—colon cancer	0.000245	0.00264	CcSEcCtD
Glipizide—Visual impairment—Methotrexate—colon cancer	0.000244	0.00264	CcSEcCtD
Glipizide—Confusional state—Capecitabine—colon cancer	0.000244	0.00263	CcSEcCtD
Glipizide—Oedema—Capecitabine—colon cancer	0.000242	0.00261	CcSEcCtD
Glipizide—Dizziness—Irinotecan—colon cancer	0.000239	0.00258	CcSEcCtD
Glipizide—Shock—Capecitabine—colon cancer	0.000238	0.00257	CcSEcCtD
Glipizide—Eye disorder—Methotrexate—colon cancer	0.000236	0.00256	CcSEcCtD
Glipizide—Diarrhoea—Fluorouracil—colon cancer	0.000236	0.00256	CcSEcCtD
Glipizide—Thrombocytopenia—Capecitabine—colon cancer	0.000236	0.00256	CcSEcCtD
Glipizide—Vomiting—Vincristine—colon cancer	0.000236	0.00255	CcSEcCtD
Glipizide—Rash—Vincristine—colon cancer	0.000234	0.00253	CcSEcCtD
Glipizide—Hyperhidrosis—Capecitabine—colon cancer	0.000233	0.00252	CcSEcCtD
Glipizide—Dermatitis—Vincristine—colon cancer	0.000233	0.00252	CcSEcCtD
Glipizide—Headache—Vincristine—colon cancer	0.000232	0.00251	CcSEcCtD
Glipizide—Anorexia—Capecitabine—colon cancer	0.00023	0.00249	CcSEcCtD
Glipizide—Vomiting—Irinotecan—colon cancer	0.000229	0.00248	CcSEcCtD
Glipizide—Dizziness—Fluorouracil—colon cancer	0.000229	0.00247	CcSEcCtD
Glipizide—Rash—Irinotecan—colon cancer	0.000228	0.00246	CcSEcCtD
Glipizide—Dermatitis—Irinotecan—colon cancer	0.000227	0.00246	CcSEcCtD
Glipizide—Chills—Methotrexate—colon cancer	0.000227	0.00246	CcSEcCtD
Glipizide—Headache—Irinotecan—colon cancer	0.000226	0.00244	CcSEcCtD
Glipizide—Erythema—Methotrexate—colon cancer	0.00022	0.00238	CcSEcCtD
Glipizide—Nausea—Vincristine—colon cancer	0.00022	0.00238	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00022	0.00238	CcSEcCtD
Glipizide—Vomiting—Fluorouracil—colon cancer	0.00022	0.00238	CcSEcCtD
Glipizide—Insomnia—Capecitabine—colon cancer	0.000218	0.00236	CcSEcCtD
Glipizide—Rash—Fluorouracil—colon cancer	0.000218	0.00236	CcSEcCtD
Glipizide—Dermatitis—Fluorouracil—colon cancer	0.000218	0.00235	CcSEcCtD
Glipizide—Paraesthesia—Capecitabine—colon cancer	0.000217	0.00235	CcSEcCtD
Glipizide—Headache—Fluorouracil—colon cancer	0.000217	0.00234	CcSEcCtD
Glipizide—Dyspnoea—Capecitabine—colon cancer	0.000215	0.00233	CcSEcCtD
Glipizide—Nausea—Irinotecan—colon cancer	0.000214	0.00232	CcSEcCtD
Glipizide—Dyspepsia—Capecitabine—colon cancer	0.000213	0.0023	CcSEcCtD
Glipizide—Decreased appetite—Capecitabine—colon cancer	0.00021	0.00227	CcSEcCtD
Glipizide—Gastrointestinal disorder—Capecitabine—colon cancer	0.000209	0.00225	CcSEcCtD
Glipizide—Vision blurred—Methotrexate—colon cancer	0.000208	0.00225	CcSEcCtD
Glipizide—Constipation—Capecitabine—colon cancer	0.000207	0.00223	CcSEcCtD
Glipizide—Pain—Capecitabine—colon cancer	0.000207	0.00223	CcSEcCtD
Glipizide—Nausea—Fluorouracil—colon cancer	0.000205	0.00222	CcSEcCtD
Glipizide—Ill-defined disorder—Methotrexate—colon cancer	0.000204	0.00221	CcSEcCtD
Glipizide—Feeling abnormal—Capecitabine—colon cancer	0.000199	0.00215	CcSEcCtD
Glipizide—Malaise—Methotrexate—colon cancer	0.000199	0.00215	CcSEcCtD
Glipizide—Vertigo—Methotrexate—colon cancer	0.000198	0.00214	CcSEcCtD
Glipizide—Gastrointestinal pain—Capecitabine—colon cancer	0.000197	0.00214	CcSEcCtD
Glipizide—Leukopenia—Methotrexate—colon cancer	0.000197	0.00213	CcSEcCtD
Glipizide—Urticaria—Capecitabine—colon cancer	0.000192	0.00207	CcSEcCtD
Glipizide—Abdominal pain—Capecitabine—colon cancer	0.000191	0.00206	CcSEcCtD
Glipizide—Arthralgia—Methotrexate—colon cancer	0.000188	0.00203	CcSEcCtD
Glipizide—Myalgia—Methotrexate—colon cancer	0.000188	0.00203	CcSEcCtD
Glipizide—Discomfort—Methotrexate—colon cancer	0.000185	0.002	CcSEcCtD
Glipizide—Confusional state—Methotrexate—colon cancer	0.000181	0.00196	CcSEcCtD
Glipizide—Hypersensitivity—Capecitabine—colon cancer	0.000178	0.00192	CcSEcCtD
Glipizide—Thrombocytopenia—Methotrexate—colon cancer	0.000176	0.0019	CcSEcCtD
Glipizide—Hyperhidrosis—Methotrexate—colon cancer	0.000174	0.00188	CcSEcCtD
Glipizide—Asthenia—Capecitabine—colon cancer	0.000173	0.00187	CcSEcCtD
Glipizide—Anorexia—Methotrexate—colon cancer	0.000171	0.00185	CcSEcCtD
Glipizide—Pruritus—Capecitabine—colon cancer	0.000171	0.00185	CcSEcCtD
Glipizide—Diarrhoea—Capecitabine—colon cancer	0.000165	0.00179	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000164	0.00177	CcSEcCtD
Glipizide—Insomnia—Methotrexate—colon cancer	0.000163	0.00176	CcSEcCtD
Glipizide—Paraesthesia—Methotrexate—colon cancer	0.000161	0.00175	CcSEcCtD
Glipizide—Dyspnoea—Methotrexate—colon cancer	0.00016	0.00173	CcSEcCtD
Glipizide—Somnolence—Methotrexate—colon cancer	0.00016	0.00173	CcSEcCtD
Glipizide—Dizziness—Capecitabine—colon cancer	0.00016	0.00173	CcSEcCtD
Glipizide—Dyspepsia—Methotrexate—colon cancer	0.000158	0.00171	CcSEcCtD
Glipizide—Decreased appetite—Methotrexate—colon cancer	0.000156	0.00169	CcSEcCtD
Glipizide—Gastrointestinal disorder—Methotrexate—colon cancer	0.000155	0.00168	CcSEcCtD
Glipizide—Pain—Methotrexate—colon cancer	0.000154	0.00166	CcSEcCtD
Glipizide—Vomiting—Capecitabine—colon cancer	0.000154	0.00166	CcSEcCtD
Glipizide—Rash—Capecitabine—colon cancer	0.000152	0.00165	CcSEcCtD
Glipizide—Dermatitis—Capecitabine—colon cancer	0.000152	0.00165	CcSEcCtD
Glipizide—Headache—Capecitabine—colon cancer	0.000151	0.00164	CcSEcCtD
Glipizide—Feeling abnormal—Methotrexate—colon cancer	0.000148	0.0016	CcSEcCtD
Glipizide—Gastrointestinal pain—Methotrexate—colon cancer	0.000147	0.00159	CcSEcCtD
Glipizide—Nausea—Capecitabine—colon cancer	0.000143	0.00155	CcSEcCtD
Glipizide—Urticaria—Methotrexate—colon cancer	0.000143	0.00154	CcSEcCtD
Glipizide—Abdominal pain—Methotrexate—colon cancer	0.000142	0.00154	CcSEcCtD
Glipizide—Hypersensitivity—Methotrexate—colon cancer	0.000132	0.00143	CcSEcCtD
Glipizide—Asthenia—Methotrexate—colon cancer	0.000129	0.0014	CcSEcCtD
Glipizide—Pruritus—Methotrexate—colon cancer	0.000127	0.00138	CcSEcCtD
Glipizide—Diarrhoea—Methotrexate—colon cancer	0.000123	0.00133	CcSEcCtD
Glipizide—Dizziness—Methotrexate—colon cancer	0.000119	0.00129	CcSEcCtD
Glipizide—Vomiting—Methotrexate—colon cancer	0.000114	0.00124	CcSEcCtD
Glipizide—Rash—Methotrexate—colon cancer	0.000113	0.00123	CcSEcCtD
Glipizide—Dermatitis—Methotrexate—colon cancer	0.000113	0.00122	CcSEcCtD
Glipizide—Headache—Methotrexate—colon cancer	0.000113	0.00122	CcSEcCtD
Glipizide—Nausea—Methotrexate—colon cancer	0.000107	0.00115	CcSEcCtD
